TITLE

Generic Protonix Launched

PUB. DATE
February 2011
SOURCE
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p76
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports that several drug suppliers including Dr. Reddy's Laboratories Ltd., Mylan Inc.'s Matrix Laboratories have announced plans to introduce generic versions of the heartburn prescription medication Protonix which went off with its patent in 2011 in the U.S.
ACCESSION #
59994655

 

Related Articles

  • Dr Reddy's launches Olanzapine tablets.  // PharmaWatch: CNS;Jun2012, Vol. 11 Issue 6, p23 

    The article reports on the launch of Dr. Reddy's Laboratories Ltd.'s olanzapine tablets, which is the generic version of the Zyprexa tablets in the U.S.

  • Dr. Reddy's.  // Chain Drug Review;9/30/2013, Vol. 35 Issue 15, p119 

    The article offers information on Bridgewater, New Jersey-based Dr. Reddy's Laboratories Ltd., with a wide portfolio of products and services offerings including approved pharmaceutical ingredients (APIs) and generics and informs that its products rank 10th on a list of the most prescribed drugs.

  • Dr. Reddy's Announces the Launch of Rivastigmine Tartrate Capsules.  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p1012 

    The article offers brief information on the Rivastigmine tartrate capsules, a bioequivalent generic version of EXELON brand, from Dr. Reddy's Laboratories Ltd.

  • Generic Drug Blockbusters Timed for Yearly Release. G. P. // Global Finance;Oct2009, Vol. 23 Issue 9, p20 

    The article focuses on the strategic plan of pharmaceutical company Dr. Reddy's Laboratories Ltd. in Hyderabad, India. It states that Dr. Reddy is India's second-biggest drug company and is the major supplier of generic drugs worldwide. It adds that the drug company has planned to increase its...

  • New PRODUCTS.  // Drug Store News;9/16/2013, Vol. 35 Issue 9, p24 

    The article offers information on several generic drugs including those for treating epilepsy from Dr. Reddy's Laboratories Ltd., for brain cancer glioblastoma multiforme from Teva Pharmaceuticals Industries Ltd. and Perrigo Co., and for chronic angina from Lupin Ltd.

  • Dr. Reddy's Now Ranked 7th Among the Leading US Generics Companies.  // Drug Topics;Aug2014 Supplement, p20s 

    The article presents a corporate profile of generic pharmaceutical company Dr. Reddy Laboratories Ltd., ranked as the seventh leading generic company, in the U.S. It stats that the company became one of the top suppliers of generic active pharmaceutical ingredients (API) not just in the country...

  • Dr Reddy's launch of Ziprasidone.  // BioSpectrum;Apr2012, Vol. 10 Issue 4, p68 

    The article reports on the launch of the Ziprasidone Hydrochloride capsules, a bioequivalent generic version of Geodon, by Dr. Reddy's Laboratories Ltd. in the U.S. market.

  • Dr. Reddy's bullish on North America and emerging markets.  // FRPT- Chemical Snapshot;7/27/2015, p24 

    The article reports on pharmaceutical company Dr. Reddy's Laboratories' (DRL) optimistic outlook for its generics business in North America and emerging markets in fiscal 2016 and mentions the planned launch of new formulations.

  • Dr. Reddy's.  // Drug Store News;2/11/2008, Vol. 30 Issue 2, p63 

    The article profiles Dr. Reddy's Laboratories Ltd. in the U.S. It provides patients with high-quality generic medicines at low-cost prices and develops new treatments for unmet medical needs. It plans to purchase its product development and state-of-the-art manufacturing capabilities. Dr....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics